The two most common types of skin cancer are basal cell and squamous cell carcinoma, well known as nonmelanoma skin cancers. These cancers are the most common malignant tumors in white population and its incidence is increasing dramatically. Information about the time of occurrence and cancer growth rate is a significant segment in establishing the primary skin cancer diagnosis. The aim of this prospective study is to determine the correlation between the size of basocellular and squamous cell carcinoma, represented through the function of cancer diameter and time period elapsed from their occurrence up to the surgical intervention. Apart from general anamnestic data, it was also insisted on as precise as possible datum referring to the cancer occurrence time. All cancers have been hystopathologically confirmed. Linear regressive analysis was used for establishing the interdependence between the diameters of tumors and their duration. The average growth of basocellular carcinoma in our patients was 4.3 mm on annual basis, i.e. 6.1 mm annually for squamous cell carcinoma. Tumor duration is a significant anamnestic datum for establishing diagnosis which can indicate a biological aggressiveness or skin cancer type.
Ridky T. Nonmelanoma skin cancer Journal of the American Academy of Dermatology. (3):484–501.
2.
Mcguire J, Ge N, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior. American Journal of Otolaryngology. (2):121–33.
3.
Ceylan C, Ozturk G, Alper S. Non -melanomatous skin cancers between the years of 1990 and 1999 in Izmir, Turkey: demographic and clinicopathological characteristics. J Dermatol. :123–31.
4.
Madan V, Lear J, Szeimies R. Non-melanoma skin cancer. The Lancet. (97):673–85.
5.
Medhaug I, Olseth J, Reuder J. UV radiation and skin cancer in Norway. Journal of Photochemistry and Photobiology. (3):232–41.
6.
Saraiya M, Glanz K, Briss P. Interventions to Prevent Skin Cancer by Reducing Exposure to Ultraviolet Radiation. Am J Prev Med. (5):422–66.
7.
Reichrath J. Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups? The Journal of Steroid Biochemistry and Molecular Biology. (3–5):664–7.
8.
Tamakawa K. Polycyclic Aromatic Hydrocarbons. Comprehensive Analytical Chemistry. :599–651.
9.
Dewberry C, Norman R. Skin cancer in elderly patients. Dermatologic Clinics. (1):93–6.
10.
De Rijke J, Schouten L, Hillen H. Cancer in the very elderly Dutch population. Cancer. :1121–33.
11.
Castori M, Castiglia D, Passarelli F, Paradisi M. Bazex-Dupré-Christol syndrome: An ectodermal dysplasia with skin appendage neoplasms. European Journal of Medical Genetics. (4):250–5.
12.
Emmet J, Rourke G. History of the occurrence and treatment of skin tumors. :3–14.
13.
Katiyar S. UV-induced immune suppression and photocarcinogenesis: Chemoprevention by dietary botanical agents. Cancer Letters. (1):1–11.
14.
Weinstock M. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch-Dermatol. (10):1286–90.
15.
Oivanen T, Kojok, Pylkkänen L, Holli K, Auvinen A. Early detection of skin cancer as public health policy: Comparison of campaign and routine activity. Preventive Medicine. (2):160–5.
16.
Breuniger H, Shaumburg-Lever G. Control of excisional margins by conventional histopathological techniques in the treatment of skin tumours. An alternative to Mohs technique. Journal of Pathology. :167–71.
17.
Boyd A, Shyr Y, Lloyd. Basal cell carcinoma in young women: an evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol. :706–9.
18.
Boyle P, Dore JF, Autier P, Ringborg U. Cancer of the skin : a forgotten problem in Europe. Annals of Oncology. :5–6.
19.
Hexsel C, Eide M, Johnson C, Krajenta R, Jacobsen G, Hamzavi I, et al. Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo. Journal of the American Academy of Dermatology. (6):929–33.
20.
Madan V, Lear J, Szeimies RM. Nonmelanoma skin cancer The Lancet. (97):673–85.
21.
Lee D, Miller S. Nonmelanoma Skin Cancer Facial Plastic Surgery Clinics of North America. (3):309–24.
22.
Rabe J, Mamelak A, Mcelgunn P, Morison W, Sauder D. Photoaging: Mechanisms and repair. Journal of the American Academy of Dermatology. (1):1–19.
23.
Zuazaga J, Olbricht S. Cutaneous Squamous Cell Carcinoma. Advances in Dermatology. :33–57.
24.
Wong C, Strange R, Lear J. Basal cell carcinomaclinical review. BMJ l. :794–8.
25.
Ridky T. Nonmelanoma skin cancer Journal of the American Academy of Dermatology. (3):484–501.
26.
Videnoviae G. Zastupljenost bazocelularnog i planocelularnog karcinoma kože lica na teritoriji Leskovca i Prištine. Magistarski rad.
27.
Woerle B, Heckmann M, Konz B. Microgrephic surgery of basal cell carcinomas of the head. Recent Results Cancer. :219–24.
28.
Kumar P, Watson S, Brain A, Davenport P, Mcwuillian L, Banerjee S, et al. Incomplete excision of basal cell carcionoma: a prospective multicentre audit. Br J Plastic Surg. (7):616–22.
29.
Ge N, Mcguire J, Dyson S, Chark D. Nonmelanoma skin cancer of the head and neck II: surgical treatment and reconstruction. American Journal of Otolaryngology. (3):181–92.
30.
Mcguire J, Ge N, Dyson S. Nonmelanoma skin cancer of the head and neck I: histopathology and clinical behavior. American Journal of Otolaryngology. (2):121–33.
31.
Mosterd K, Krekels G, Nieman F, Ostertag J, Essers A. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ followup. The Lancet Oncology. (12):1149–56.
32.
Breuniger H, Dietz K. Prediction of Subclinical Tumor Infiltration in Basal Cell Carcinoma. J Dermatol Surg Oncol. :574–8.
33.
Mantese S, Berbert A, Gomides M, Rocha A. Basal cell Carcinoma -Analysis of 300 cases observed in Uberlândia. An Bras Dermatol. (2):136–42.
34.
Friedman H, Cooper P, Wanebo H. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. (10):99–105.
35.
Mcgregor I, Mc Gregor F. Cancer of the Face and Mouth-Pathology and management for surgeons. :55–106.
36.
Kwa R, Campana K, Moy R. Biology of cutaneus squamous cell carcinoma. J Am Acad Dermatol. :1–26.
37.
Rowe D, Carroll R, Day C. Prognostic factors for local recurrence, metastasis, survival rates in squamous cell carcinoma of the skin, ear and lip: implications for treatment modality selection. J Am Acad Dermatol. :976–90.
38.
Jensen V, Prasad A, Smith A, Raju M, Wendel C. Prognostic Criteria for Squamous Cell Cancer of the Skin Journal of Surgical. Research. (1):509–16.
39.
Immerman S, Scanlon E, Christ M. Recurrent squamous cell carcinoma of the skin. Cancer. (15):37–40.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
